131 related articles for article (PubMed ID: 1645746)
41. Modulation of leukotriene release from human polymorphonuclear leucocytes by PMA and arachidonic acid.
Raulf M; König W
Immunology; 1988 May; 64(1):51-9. PubMed ID: 2838420
[TBL] [Abstract][Full Text] [Related]
42. Erythrocytes increase leukotriene C4 release from human eosinophils: characterization and examination of possible mechanisms.
Raible DG
J Leukoc Biol; 1994 Jul; 56(1):65-73. PubMed ID: 8027672
[TBL] [Abstract][Full Text] [Related]
43. The generation and cellular distribution of leukotriene C4 in human eosinophils stimulated by unopsonized zymosan and glucan particles.
Mahauthaman R; Howell CJ; Spur BW; Youlten LJ; Clark TJ; Lessof MH; Lee TH
J Allergy Clin Immunol; 1988 Apr; 81(4):696-705. PubMed ID: 3128590
[TBL] [Abstract][Full Text] [Related]
44. A morphometric study of normodense and hypodense human eosinophils that are derived in vivo and in vitro.
Caulfield JP; Hein A; Rothenberg ME; Owen WF; Soberman RJ; Stevens RL; Austen KF
Am J Pathol; 1990 Jul; 137(1):27-41. PubMed ID: 2196816
[TBL] [Abstract][Full Text] [Related]
45. IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity.
Rothenberg ME; Petersen J; Stevens RL; Silberstein DS; McKenzie DT; Austen KF; Owen WF
J Immunol; 1989 Oct; 143(7):2311-6. PubMed ID: 2506282
[TBL] [Abstract][Full Text] [Related]
46. Regulation of human eosinophil degranulation and activation by endogenous phospholipase A2.
White SR; Strek ME; Kulp GV; Spaethe SM; Burch RA; Neeley SP; Leff AR
J Clin Invest; 1993 May; 91(5):2118-25. PubMed ID: 8387540
[TBL] [Abstract][Full Text] [Related]
47. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M
Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651
[TBL] [Abstract][Full Text] [Related]
48. The identification of a distinct export step following the biosynthesis of leukotriene C4 by human eosinophils.
Lam BK; Owen WF; Austen KF; Soberman RJ
J Biol Chem; 1989 Aug; 264(22):12885-9. PubMed ID: 2753893
[TBL] [Abstract][Full Text] [Related]
49. Comparison of two modified techniques for purifying blood eosinophils.
Laviolette M; Bossé M; Rocheleau H; Lavigne S; Ferland C
J Immunol Methods; 1993 Oct; 165(2):253-61. PubMed ID: 8228275
[TBL] [Abstract][Full Text] [Related]
50. Priming of the human neutrophil respiratory burst by granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha involves regulation at a post-cell surface receptor level. Enhancement of the effect of agents which directly activate G proteins.
McColl SR; Beauseigle D; Gilbert C; Naccache PH
J Immunol; 1990 Nov; 145(9):3047-53. PubMed ID: 2170531
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of eosinophil density change and leukotriene C4 generation by nedocromil sodium.
Sedgwick JB; Bjornsdottir U; Geiger KM; Busse WW
J Allergy Clin Immunol; 1992 Aug; 90(2):202-9. PubMed ID: 1323588
[TBL] [Abstract][Full Text] [Related]
52. Platelet-activating factor (PAF-acether) induced leukotriene C4 formation and luminol dependent chemiluminescence by human eosinophils.
Bruynzeel PL; Koenderman L; Kok PT; Hameling ML; Verhagen J
Pharmacol Res Commun; 1986 Aug; 18 Suppl():61-9. PubMed ID: 3774850
[TBL] [Abstract][Full Text] [Related]
53. Platelet-activating factor production in human neutrophils by sequential stimulation with granulocyte-macrophage colony-stimulating factor and the chemotactic factors C5A or formyl-methionyl-leucyl-phenylalanine.
Wirthmueller U; De Weck AL; Dahinden CA
J Immunol; 1989 May; 142(9):3213-8. PubMed ID: 2540238
[TBL] [Abstract][Full Text] [Related]
54. Bafetinib inhibits functional responses of human eosinophils in vitro.
Milara J; Martinez-Losa M; Sanz C; Almudéver P; Peiró T; Serrano A; Morcillo EJ; Zaragozá C; Cortijo J
Eur J Pharmacol; 2013 Sep; 715(1-3):172-80. PubMed ID: 23747655
[TBL] [Abstract][Full Text] [Related]
55. A specific radioreceptor assay for leukotriene C4 and the measurement of calcium ionophore-induced leukotriene C4 production from human leukocytes.
Tamura N; Agrawal DK; Townley RG
J Pharmacol Methods; 1987 Dec; 18(4):327-33. PubMed ID: 3695541
[TBL] [Abstract][Full Text] [Related]
56. Relationship between LTC4 generation of hypodense eosinophils and bronchial hyperreactivity in asthmatic children.
Schauer U; Daume U; Müller R; Riedel F; Gemsa D; Rieger CH
Int Arch Allergy Appl Immunol; 1990; 92(1):82-7. PubMed ID: 2246079
[TBL] [Abstract][Full Text] [Related]
57. Recombinant human tumour necrosis factor (rTNF)2 enhances leukotriene biosynthesis in neutrophils and eosinophils stimulated with the Ca2+ ionophore A23187.
Roubin R; Elsas PP; Fiers W; Dessein AJ
Clin Exp Immunol; 1987 Nov; 70(2):484-90. PubMed ID: 2827923
[TBL] [Abstract][Full Text] [Related]
58. Cellular communication in leukotriene C4 production between eosinophils and neutrophils.
Kloprogge E; de Leeuw AJ; de Monchy JG; Kauffman HF
Int Arch Allergy Appl Immunol; 1989; 90(1):20-3. PubMed ID: 2509375
[TBL] [Abstract][Full Text] [Related]
59. FMLP is a potent activator of guinea-pig eosinophils but its activity is dependent on the prior overnight in vitro culture of the cells (facilitation).
Bach MK; Brashler JR
Immunology; 1992 Apr; 75(4):680-7. PubMed ID: 1317350
[TBL] [Abstract][Full Text] [Related]
60. Leukotriene C4 formation by purified human eosinophils can be induced by arachidonic acid in the absence of calcium-ionophore A23187.
Kok PT; Hamelink ML; Kijne GM; Verhagen J; Koenderman L; Veldink GA; Bruynzeel PL
Agents Actions; 1989 Jan; 26(1-2):96-8. PubMed ID: 2496595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
